Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Current treatment strategies for multiple myeloma]Ulrich J M Mey
Hematological Oncology|April 23, 2015
Improved survival of older patients with multiple myeloma in the era of novel agentsUlrich J M Mey, Christoph Leitner, Christoph Driessen, et al.
Hematological Oncology|May 16, 2022
Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life settingMurielle Lalive d'Epinay, Sabine Güsewell, Nicole Graf, et al.
German Medical Science : GMS E-Journal|August 14, 2009
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphomaUlrich J M Mey, Vandana Jha, John W Strehl, et al.
Cancer Investigation|September 17, 2016
Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin LymphomaNadine G D Schirmbeck, Ulrich J M Mey, Attilio Olivieri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 20, 2007
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphomaUlrich J M Mey, Anna Maier, Ingo G H Schmidt-Wolf, et al.
Swiss Medical Weekly|October 27, 2024
Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficienciesJeroen S Goede, Christa K Baumann, Richard Cathomas, et al.
Haematologica|December 7, 2007
Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemiaThomas Burmeister, Stefan Schwartz, Almut Taubald, et al.
Pageof 2